# TRICuspid Intervention in Heart Failure Trial

> **NCT04634266** · NA · ACTIVE_NOT_RECRUITING · sponsor: **LMU Klinikum** · enrollment: 360 (estimated)

## Conditions studied

- Heart Failure Attributable to Severe Tricuspid Regurgitation

## Interventions

- **DEVICE:** Transcatheter tricuspid valve treatment (TTVT)

## Key facts

- **NCT ID:** NCT04634266
- **Lead sponsor:** LMU Klinikum
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-03-25
- **Primary completion:** 2026-07-01
- **Final completion:** 2028-10-01
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2026-05-08

## Collaborators

- Heart and Diabetes Center North Rhine-Westphalia
- University Medical Center Mainz
- Heart Center Leipzig - University Hospital
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04634266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04634266, "TRICuspid Intervention in Heart Failure Trial". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT04634266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*